Company:  ZIOPHARM ONCOLOGY INC (ZIOP)
Form Type:  S-3ASR
Filing Date:  6/21/2019 
CIK:  0001107421 
Address:  ONE FIRST AVENUE
PARRIS BUILDING 34, NAVY YARD PLAZA
 
City, State, Zip:  BOSTON, Massachusetts 02129 
Telephone:  617-259-1970 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.73  
Change: 
0.00 (0.00%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$768.88M
Trade ZIOP now with

© 2019  
Description of Business
We are a biopharmaceutical company focused on discovering, acquiring, developing and commercializing next generation immunotherapy platforms that leverage cell- and gene-based therapies to treat patients with cancer. We are developing two immuno-oncology platform technologies that utilize the patient's immune system by employing novel, controlled gene expression and innovative cell engineering technologies to designed deliver safe, effective, and scalable cell- and viral-based therapies for the treatment of multiple cancer types. Our first platform is referred to as Sleeping Beauty and is based on the genetic engineering of immune cells using a non-viral transposon/transposase system to stably reprogram T cells outside of the body for subsequent infusion.
Register and access this filing in:     
  FORM S-3ASR
    THE OFFERING
    EXPLANATORY NOTE
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DILUTION
    DESCRIPTION OF CAPITAL STOCK
    DESCRIPTION OF DEBT SECURITIES
    DESCRIPTION OF WARRANTS
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    RISK FACTORS
    USE OF PROCEEDS
    PART II
      Item 14. Other Expenses of Issuance and Distribution.
      Item 15. Indemnification of Directors and Officers.
      Item 16. Exhibits and Financial Statement Schedules.
      Item 17. Undertakings.
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 1.2
  EXHIBIT 4.3
  EXHIBIT 4.5
  EXHIBIT 4.6
  EXHIBIT 4.7
  EXHIBIT 5.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM